Twareat Medical Care Co. Board invites its shareholders to attend the Ordinary General Assembly Meeting the (First Meeting)

Twareat Medical Care Company invited shareholders to its Ordinary General Assembly Meeting scheduled for June 30, 2026, to be held remotely via the Tadawulaty platform.
The agenda includes reviewing FY 2025 financial statements, appointing an auditor for 2026, and authorizing the Board of Directors to distribute interim dividends for the 2026 fiscal year.
Shareholders will vote on related party contracts with Urgent Care Pharmacy Company (linked to Vice Chairman Dr. Tariq Mohammed Sulaiman Al-Hamdan) for an expected annual value of SAR 1 million.
Other items for approval include amendments to the remuneration policy for board members and executive management, as well as the company’s credit risk policy.

Element List	Explanation
Introduction	The Board of Directors of Twareat Medical Care Company invites the shareholders to participate and vote in the Ordinary General Assembly Meeting on Tuesday, 15/01/1448 corresponding to 30/06/2026 through modern technology means using the Tadawulaty platform.
City and Location of the General Assembly's Meeting	Through modern technology (remotely) at the company's headquarters in Al Khobar.
Hyperlink of the Meeting Location	Click Here
Date of the General Assembly's Meeting	2026-06-30 Corresponding to 1448-01-15
Time of the General Assembly’s Meeting	20:05
Methodology of Convening the General Assembly’s Meeting	Via modern technology means
Attendance Eligibility, Registration Eligibility, and Voting End	Shareholders who are registered in the issuers shareholders record at the Depositary Center by the end of the trade session prior to the general assembly meeting and in accordance with the laws and regulations. The shareholder has the right to delegate whomever other than the board of directors. The right to register a name to attend the general assembly meeting ends at the time of convening the general assembly meeting. The attendees right to vote on the items of the assembly’s agenda ends upon the end of screening the votes by the Screening Committee.
Quorum for Convening the General Assembly's Meeting	Tuesday , 15/01/1448 AH corresponding to 30/06/2026 AD
General Assembly Meeting Agenda	1- Review and discuss the Board of Directors' report for the fiscal year ended 31/12/2025. 2- Review and discuss the Company's financial statements for the financial year ended 31/12/2025. 3. Vote on the auditor's report for the financial year ended 31/12/2025 after discussing it. 4. Vote on the appointment of an auditor for the company from among the candidates based on the recommendation of the Audit Committee, in order to examine, review and audit the financial statements for the second and third quarter of 2026, the annual financial statements ended on 31/12/2026, and the financial statements for the first quarter of 2027, and determine his fees. 5. Vote on the discharge of the members of the Board of Directors for the financial year ending on 31/12/2025. 6. Vote on authorizing the Board of Directors to distribute interim dividends to shareholders on a semi- or quarterly basis for the financial year ending 31 December 2026. 7- Voting on the works and contracts that will be executed between the company and the Urgent Care Pharmacy Company, in which the member of the Board of Directors (Dr. Tariq Mohammed Sulaiman Al-Hamdan in his capacity as Vice Chairman of the Board of Directors) has a direct interest, which is the sale/purchase of medicines, supplies, medical devices and mobile clinics without preferential conditions with an expected annual amount of one million riyals for a calendar year, noting that the value of transactions for the previous year is 87,347 Saudi riyals. 8. Vote on authorizing the Board of Directors to authorize the Ordinary General Assembly with the license stipulated in paragraph (1) of Article Twenty-Seven of the Companies Law, for a period of one year from the date of approval of the General Assembly or until the end of the session of the delegated Board of Directors, whichever is earlier, in accordance with the conditions set forth in the Executive Bylaws of the Companies Law for listed joint stock companies. 9. Vote on the credit risk policy and the provision for expected credit losses. 10. Vote on amending the remuneration policy and standards of the members of the Board of Directors, its subordinate committees, and the Executive Management.
Proxy Form	Proxy Form
The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right	The right to register to attend the meeting of the Assembly ends at the time of the meeting of the Society, and the right to vote on the items of the Assembly shall be for the attendees and shall end when the Counting Committee has finished counting the votes. The Ordinary General Assembly Meeting shall be valid if it is attended by shareholders representing (at least one quarter of the capital) and if the necessary quorum is not available to hold this meeting, a second meeting shall be held one hour after the expiry of the period specified for the first meeting, and the second meeting shall be valid regardless of the number of shares that have voting rights represented in it. Quorum Required for the General Assembly
Details of the electronic voting on the Assembly’s agenda	shareholders can register and vote electronically remotely on the items of the General Assembly starting from 01:00 am on Friday26/06/2026 until the end of the meeting time. Registration and voting will be available in the Tadawulaty service for free of charge to all shareholders through the link: (www.tadawulaty.com.sa)
Method of Communication in Case of Any Enquiries	In case of any inquiries or questions related to the meeting items, the valued shareholders can send them electronically to the following emails: investors.relations@twareat.com
Additional Information	NA
Attached Documents	Attached Documents Attached Documents Attached Documents Attached Documents Attached Documents